In the next episode of The Cure Chronicles, Dr. Deanna Kulpa, an assistant professor at Emory University, joins the conversation. After earning her Ph.D. in Human Genetics from the University of Michigan, Dr. Kulpa’s postdoctoral training focused on HIV mechanisms of immune system invasion, and today, her work largely focuses on defining the mechanisms that promote HIV persistence in ART-treated individuals living with HIV.
Dr. Kulpa recently co-founded the Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) collaboratory, where we see the intersection of HIV cure research and advocacy as researchers share scientific findings with the community, and gain valuable insights from community members living with HIV. The ERASE-HIV initiative received a five-year, $23.8 million grant from the NIH as one of 10 newly-funded Martin Delaney Collaboratories for HIV Cure Research programs.
About The Cure Chronicles:
There are more than 38 million people in the world currently living with HIV/AIDS. At American Gene Technologies® (AGT™), we believe there is hope for a cure. But it will take everyone working together to make it a reality and permanently end the suffering of millions of people living with HIV today.
AGT is testing a single-infusion cell therapy (AGT103-T) to hopefully cure people living with HIV. Meanwhile, we want to spotlight some of the many people in the HIV community who strive to keep hope alive and tip the odds toward success.
The Cure Chronicles video series features thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working hard toward the shared goal of ending the devastating HIV epidemic.
If you like this video, please subscribe to our channel: www.youtube.co....
Also, please leave us a comment to let us know how you liked it as well as any additional subjects you’d like us to cover.
About American Gene Technologies:
AGT is a clinical-stage, gene and cell therapy company in Rockville, Maryland with a proprietary gene-delivery platform for rapid drug development of infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease.
Visit our website: www.americange...
Subscribe to our newsletter: bit.ly/3ughPNR
Follow AGT on social media!
Twitter:
Jeff - @jeffreygalvin - / jeffreygalvin
AGT™ - @americangene - / americangene
LinkedIn:
Jeff - / jeff-galvin
AGT™ - / amer. .
Facebook: / amerigene
Instagram: / americangenetechnologies
21 сен 2024
